Edwards Lifesciences Corporation (EW)

NYQ – Real vaqt narxi. Valyuta: USD

90.78

+1.06 (1.18%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

91.35

+0.57 (0.63%)

Bozordan keyin: Jun 26, 2026, 7:11 PM EDT

16.06.2026

Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device

On Monday, the Centers for Medicare & Medicaid Services (CMS) proposed removing the coverage with evidence development (CED) requirement for Transcatheter Aortic Valve Replacement (TAVR) in patients with symptomatic severe aortic stenosis.

12.06.2026

Should You Continue to Hold EW Stock in Your Portfolio?

Edwards gains from strong TMTT growth, RESILIA adoption and expanding TAVR use, but macro pressures and currency swings remain key risks.

12.06.2026

East West Announces $858,000 Non-Brokered Private Placement

Vancouver, British Columbia--(Newsfile Corp. - June 12, 2026) - East West Minerals Ltd. (TSXV: EW) ("East West" or the "Company") announces that further to a price reservation filed on June 10, 2026, the Company has arranged a non-brokered private placement financing (the "Financing") of up to 7,800,000 units (each a "Unit"), at a price of $0.11 per Unit, to raise up to $858,000.

13.05.2026

Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript

10.05.2026

AI, Obesity Drugs, and Diagnostics Fuel Healthcare Growth

Healthcare is regaining momentum as innovation—especially AI‑driven drug discovery—creates new growth opportunities, according to Shivani Vohra. She points to obesity treatments from Eli Lilly (LLY) and Novo Nordisk (NVO), advances in diagnostics from Natera (NTRA), and continued strength in med tech leaders like Intuitive Surgical (ISRG) and Edwards Lifesciences (EW) as key areas of expansion.

04.05.2026

Edwards Lifesciences Announces Appointment of CFO

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced the appointment of Theodora (“Doretta”) Mistras as the company's corporate vice president and chief financial officer (CFO), effective at the end of May. Mistras will succeed Scott Ullem, who announced in October his planned transition from the CFO role. Mistras joins Edwards from Viatris, where she has served as CFO since March 2024, leading the company's global finance organization and overseeing financial planni.

02.05.2026

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue

CHICAGO--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The data were presented at the 106th American Association for Thoracic Surgery Annual Meeting. As evidence increasingly supports treating patients earlier in the valve disease pathway, the need for durable valve solutions continues to grow. The COMMENCE trial provides prospectiv.

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue

23.04.2026

Edwards Lifesciences Reports First Quarter Results

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2026. Highlights and Outlook Q1 sales grew 16.7% to $1.65 billion1, constant currency2 sales grew 12.7% Q1 TAVR sales grew 14.4% to $1.20 billion1; constant currency2 sales grew 11.0% Q1 TMTT sales of $173 million1,3, driven by repair and replacement therapies Q1 EPS of $0.661; adjusted2 EPS of $0.781 Raising FY 2026 constant currency2 sales growth guidance to 9% to.

Edwards Lifesciences Corporation (EW)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device

Should You Continue to Hold EW Stock in Your Portfolio?

East West Announces $858,000 Non-Brokered Private Placement

Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript

AI, Obesity Drugs, and Diagnostics Fuel Healthcare Growth

Edwards Lifesciences Announces Appointment of CFO

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue

Videolar

Press-relizlar

East West Announces $858,000 Non-Brokered Private Placement

Edwards Lifesciences Announces Appointment of CFO

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue

Edwards Lifesciences Reports First Quarter Results

Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device

Should You Continue to Hold EW Stock in Your Portfolio?

East West Announces $858,000 Non-Brokered Private Placement

Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript

AI, Obesity Drugs, and Diagnostics Fuel Healthcare Growth

Edwards Lifesciences Announces Appointment of CFO

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue

Videolar

Press-relizlar

East West Announces $858,000 Non-Brokered Private Placement

Edwards Lifesciences Announces Appointment of CFO

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue

Edwards Lifesciences Reports First Quarter Results

Search stocks

Edwards Lifesciences Corporation (EW)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device

Should You Continue to Hold EW Stock in Your Portfolio?

East West Announces $858,000 Non-Brokered Private Placement

Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript

AI, Obesity Drugs, and Diagnostics Fuel Healthcare Growth

Edwards Lifesciences Announces Appointment of CFO

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue

Videolar

Press-relizlar

East West Announces $858,000 Non-Brokered Private Placement

Edwards Lifesciences Announces Appointment of CFO

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue

Edwards Lifesciences Reports First Quarter Results

Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device

Should You Continue to Hold EW Stock in Your Portfolio?

East West Announces $858,000 Non-Brokered Private Placement

Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript

AI, Obesity Drugs, and Diagnostics Fuel Healthcare Growth

Edwards Lifesciences Announces Appointment of CFO

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue

Videolar

Press-relizlar

East West Announces $858,000 Non-Brokered Private Placement

Edwards Lifesciences Announces Appointment of CFO

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue

Edwards Lifesciences Reports First Quarter Results